Home > PE Ratio > LAURUS LABS

LAURUS LABS
PE (Price/Earnings) Ratio

The Current P/E Ratio of LAURUS LABS is 114.80.

Share Price ₹426.3Apr 19,2024
Market Cap ₹22,974.9 Cr
Earnings-TTM₹200.1 CrTTM-Consolidated Results
Price/Earnings114.80xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for LAURUS LABS
Please provide your vote to see the results
LAURUS LABS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals

Definition & Calculation of PE (Price/Earnings) ratio of LAURUS LABS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of LAURUS LABS is calculated as :

Current Market Cap [ ₹22,974.9 Cr] as on Apr 19,2024

(/) Earnings [ ₹200.1 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 114.80x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for LAURUS LABS , the investors are currently willing to pay 114.80 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of LAURUS LABS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of LAURUS LABS over the last five years.

Historical PE (Price/Earnings) ratio chart of LAURUS LABS


PE Ratio Performance Analysis for LAURUS LABS

- LAURUS LABS 's latest p/e ratio is 114.80x.

- LAURUS LABS 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 17.99x.

- LAURUS LABS 's operated at median p/e ratio of 19.75x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, LAURUS LABS 's p/e ratio peaked in Mar2022 at 38.31x.

- LAURUS LABS 's p/e ratio hit its five-year low in Mar2020 of 2.7x.


How does LAURUS LABS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
LAURUS LABS 200.13114.8022,974.9
SUN PHARMACEUTICAL INDUSTRIES LTD8,998.6340.60365,311.0
CIPLA LTD3,744.0329.01108,623.0
DR REDDYS LABORATORIES LTD5,209.4019.0399,134.3
ZYDUS LIFESCIENCES LTD2,954.2031.4192,794.9
DIVIS LABORATORIES LTD1,382.9770.4397,408.4
MANKIND PHARMA LTD1,743.3053.6793,565.4
TORRENT PHARMACEUTICALS LTD1,494.0057.4785,858.5
LUPIN LTD1,809.7438.9670,506.8
AUROBINDO PHARMA LTD2,777.8922.9363,697.4
ABBOTT INDIA LTD1,145.5848.4755,528.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs LAURUS LABS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 19.03x
Max industry PE 114.80x
Median industry PE 40.60x
Average industry PE 47.89x



You may also like the below Video Courses